If you’re looking to do clinical trials for Lyme disease-related treatments, new research funded by the Centers for Disease Control and Prevention shows that New Jersey and Wisconsin are hot spots for the disease. Durland Fish, a professor of Epidemiology at Yale School of Public Health, said the researchers had found of a search of […]
Every week, MedCity News highlights the best of its MedCitizens: syndication partners and MedCity News readers who discuss life science current events on MedCitynews.com. Now here’s the best of what YOU had to say: Baxter Ventures will invest $200 million in early-stage companies. Baxter International put aside $200 million in equity to invest in early-stage […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Baxter International Inc. (NYSE: BAX) put aside $200 million in equity to invest in early-stage companies that “complement” its portfolio. The newly established ” Baxter Ventures will invest globally and focus on innovative technologies with sustainable long-term growth” under the watch of the Deerfield, Ill.-based company’s chief scientific officer Norbert Riedel, according to a press release. […]
The U.S. Food & Drug Administration said it is requiring nine medical device companies to conduct postmarket analysis on a connection between needless connectors and higher rates of blood stream infections. In a notice posted on the Centers for Devices and Radiological Health web site, officials said that the agency is “aware of information that […]
Baxter International Inc.’s (NYSE:BAX) profits fell 9 percent due to higher costs and big write-down from a settlement with the government of Greece. The Deerfield, Ill.-based medical device and vaccine maker posted net income of $535 million for the three months ended June 30, down 9 percent from $587 million during the same period last […]
The U.S. Food & Drug Administration’s recall covers as many as 200,000 of Baxter International Inc.’s Colleague infusion pumps. The Food & Drug Administration issued its final order for the U.S. recall of Baxter International Inc.’s (NYSE:BAX) Colleague infusion pumps. The federal watchdog is requiring the Deerfield, Ill.-based company to provide transition guide for hospitals […]
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
The Food & Drug Administration warns Baxter Healthcare Corp. about problems with its HomeChoice peritoneal dialysis systems after reports of patients developing peritonitis. The Food & Drug Administration warned Baxter Healthcare Corp. (NYSE:BAX) that it has 15 days to respond to the watchdog agency’s concerns about its HomeChoice peritoneal dialysis systems, after reports surfaced of […]
The medical device industry spent at least $20 million to lobby lawmakers and federal agencies during the first quarter. The medical device industry once again spent big bucks to ensure its voice was heard in Washington during the first quarter, dropping more than $20 million on lobbying efforts for health issues at the U.S. House […]
Baxter International Inc. (NYSE:BAX) took a $39 million hit to its bottom line during the first quarter, blaming the healthcare reform act’s added tax burden and lowering its full-year guidance. The Deerfield Park, Ill.-based medical products giant posted sales of $3.14 billion during the three months ended March 31, up 11.2 percent compared with $2.82 […]
Baxter International Inc. (NYSE:BAX) named Ludwig Hantson president of its international operations, effective May 3. The Deerfield, Ill.-based medical products conglomerate said expanding its global footprint is a “key growth driver” for the company. Hantson’s pedigree is stamped by years in the pharmaceutical industry. He was CEO of Novartis Pharmaceuticals Corp.’s (NYSE:NVS) Pharma North America […]
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
Medical device makers, health information technology providers and AdvaMed together spent more than $20 million lobbying Congress, the White House and the Food & Drug Administration during the fourth quarter.
The FDA posted notice of a Class I recall of a hemodialysis system distributed by Baxter International Inc., warning that in extreme cases the machine's defect could result in serious injuries or death.